Journal of Cardiac Failure 2011-01-01

Doxercalciferol, a Pro-hormone of Vitamin D, Prevents the Development of Cardiac Hypertrophy in Rats

Jun H. Choi, Qingen Ke, Soochan Bae, Ji Yoo Lee, Yu Jin Kim, Ui Kyoung Kim, Cynthia Arbeeny, Ravi Thadhani, Peter M. Kang, Jun H. Choi, Qingen Ke, Soochan Bae, Ji Yoo Lee, Yu Jin Kim, Ui Kyoung Kim, Cynthia Arbeeny, Ravi Thadhani, Peter M. Kang

Index: J. Card. Fail. 17(12) , 1051-8, (2011)

Full Text: HTML

Abstract

Background Activated vitamin D analog, paricalcitol, has been shown to attenuate the development of cardiac hypertrophy in Dahl salt sensitive (DSS) rats. To determine whether an antihypertrophic effect is class specific, we tested if doxercalciferol (a pro-hormone vitamin D2 analog) could also attenuate the development of cardiac hypertrophy in DSS rats.

Related Compounds

Related Articles:

Calcium regulates FGF-23 expression in bone.

2013-12-01

[Endocrinology 154(12) , 4469-82, (2013)]

Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study.

2015-01-07

[Clin. J. Am. Soc. Nephrol. 10(1) , 98-109, (2015)]

A new look at the most successful prodrugs for active vitamin D (D hormone): alfacalcidol and doxercalciferol.

2009-01-01

[Molecules 14(10) , 3869-80, (2009)]

Randomized, double-blinded phase II evaluation of docetaxel with or without doxercalciferol in patients with metastatic, androgen-independent prostate cancer.

2008-04-15

[Clin. Cancer Res. 14(8) , 2437-43, (2008)]

Calcium balance in dialysis is best managed by adjusting dialysate calcium guided by kinetic modeling of the interrelationship between calcium intake, dose of vitamin D analogues and the dialysate calcium concentration.

2010-01-01

[Blood Purif. 29(2) , 163-76, (2010)]

More Articles...